Washington University School of Medicine Siteman Cancer Center — St Louis, Missouri

Washington University School of Medicine Siteman Cancer Center is a clinical research site located in St Louis, Missouri, United States.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Washington University School of Medicine Siteman Cancer Center has participated in 22 clinical trials with 5 currently active.

Therapeutic areas: Advanced Cancer, Advanced Malignancies, Neuroendocrine Tumors.

Sponsors: Regeneron Pharmaceuticals, Advanced Accelerator Applications, Pfizer.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University School of Medicine Siteman Cancer Center?

Washington University School of Medicine Siteman Cancer Center has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University School of Medicine Siteman Cancer Center conducted?

Washington University School of Medicine Siteman Cancer Center has 22 clinical trials on record, with 5 currently active. Their work covers Advanced Cancer, Advanced Malignancies, Neuroendocrine Tumors.

Is Washington University School of Medicine Siteman Cancer Center accredited by Crixeo Health?

Yes — Washington University School of Medicine Siteman Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Washington University School of Medicine Siteman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.